Externalizing disorders
Chapter D.1
Attention deficit hyperactivity disorder
The link between cholera in pregnancy and negative childbirth outcomes has been observed since the
19th century, but there is currently no clear understanding of the extent nor the mechanisms to inform
treatment guidelines. The recommendations in this Interim Technical Note are based on current
k...nowledge, including documented experiences of treating pregnant women with cholera during
epidemics.
more
Actualmente, en el mundo, el cáncer produce millones de muertes al año, generando altos costos económicos y sociales, tanto por los valores asignados al tratamiento, como por el compromiso que genera en la productividad laboral de las personas directamente afectadas y de su entorno familiar y/o c...uidadores.
more
L’ulcère de Buruli, une infection causée par Mycobacterium ulcerans, touche plus de 33 pays dans le monde, mais un peu moins de la moitié seulement de ces pays communiquent régulièrement des données sur la maladie à l’OMS.
Ce plan intégré de lutte contre les MNT au Burkina Faso tient compte dans une large mesure des résultats de cette enquête et des cibles principales du nouveau plan mondial de lutte contre les MNT 2013-20201
. S’inscrivant dans la logique du PNDS, il s’est voulu multisectoriel et intègre tr...ois principaux piliers de la stratégie mondiale de
lutte contre les maladies non transmissibles 2013-2020, à savoir la surveillance, la
prévention et la prestation de soins de santé dans le cadre de systèmes de santé.
more
Rapid review and case studies from Member States
1 July 2021; Report shows big COVID-19-related HIV prevention programme service disruptions, but highlights that HIV service innovations and adaptations are possible.
A synthesis report on programme disruptions and adaptations during the COVID-19 pandemic in 2020
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...ce of antimicrobial resistance in the foodborne bacteria (i.e., bacteria commonly transmitted by food) by taking a One Health approach.
more
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...ance of antimicrobial resistance in foodborne bacteria” is defined as the collection, validation, analyses and reporting of relevant microbiological and epidemiological data on antimicrobial resistance in foodborne bacteria from humans, animals, and food, and on relevant antimicrobial use in humans and animals. Integrated surveillance of antimicrobial resistance in foodborne bacteria therefore includes data from relevant food chain sectors (animals, food and humans) and includes data on both antimicrobial resistance and antimicrobial use. Integrated surveillance of antimicrobial resistance for foodborne bacteria expands on traditional public health surveillance to include multiple elements of the food chain, and to include antimicrobial use data, to better understand the sources of infection and transmission routes.
more
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...otype and clinical history, and assess the appropriateness of continued use of certain medicines. This document also includes existing recommendations on screening for HCV infection and care of persons infected with HCV that were first issued in 2014
more
Guide to monitoring and evaluating
F1000Research 2019, 8:323 Last updated: 17 MAY 2019